Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study

Abstract Introduction Prophylaxis and treatment of invasive aspergillosis (IA) and mucormycosis (IM) within a real-world US inpatient setting is undocumented since the introduction of isavuconazole. This retrospective medical record review aimed to describe characteristics, triazole use, and outcome...

Full description

Bibliographic Details
Main Authors: Katherine Stull, Elizabeth Esterberg, Mayank Ajmera, Sean Candrilli, Therese M. Kitt, James R. Spalding, Vanessa Perez Patel
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-10-01
Series:Infectious Diseases and Therapy
Subjects:
Antifungals
Fungal infection
Inpatient
Invasive aspergillosis
Invasive mucormycosis
Mold-active triazoles
Online Access:http://link.springer.com/article/10.1007/s40121-019-00267-4

Internet

http://link.springer.com/article/10.1007/s40121-019-00267-4

Similar Items